1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site - Ownership and Business Overview

Life ScienceCompany

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site Ownership

Who owns Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site?

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site is owned by Syngene International. It was acquired on March 19, 2025.

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site Business Overview

Where is Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site headquartered?

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site is headquartered in United States.

What sector is Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site in?

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site is a life science company.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Join Mergr to view all 55 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 52 by strategics.

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site


United States,

Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site provides drug substance manufacturing.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 212,204
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 205K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site

Life Science Companies , United States Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal